189 related articles for article (PubMed ID: 9600739)
1. De novo mutation in CACNA1A caused acetazolamide-responsive episodic ataxia.
Yue Q; Jen JC; Thwe MM; Nelson SF; Baloh RW
Am J Med Genet; 1998 May; 77(4):298-301. PubMed ID: 9600739
[TBL] [Abstract][Full Text] [Related]
2. CACNA1A mutation in a EA-2 patient responsive to acetazolamide and valproic acid.
Scoggan KA; Friedman JH; Bulman DE
Can J Neurol Sci; 2006 Feb; 33(1):68-72. PubMed ID: 16583725
[TBL] [Abstract][Full Text] [Related]
3. A novel nonsense mutation in CACNA1A causes episodic ataxia and hemiplegia.
Jen J; Yue Q; Nelson SF; Yu H; Litt M; Nutt J; Baloh RW
Neurology; 1999 Jul; 53(1):34-7. PubMed ID: 10408533
[TBL] [Abstract][Full Text] [Related]
4. A novel insertion mutation of acetazolamide-responsive episodic ataxia in a Japanese family.
Matsuyama Z; Murase M; Shimizu H; Aoki Y; Hayashi M; Hozumi I; Inuzuka T
J Neurol Sci; 2003 Jun; 210(1-2):91-3. PubMed ID: 12736095
[TBL] [Abstract][Full Text] [Related]
5. A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia.
Battistini S; Stenirri S; Piatti M; Gelfi C; Righetti PG; Rocchi R; Giannini F; Battistini N; Guazzi GC; Ferrari M; Carrera P
Neurology; 1999 Jul; 53(1):38-43. PubMed ID: 10408534
[TBL] [Abstract][Full Text] [Related]
6. A sleep modulated Channelopathy: a novel CACNA1A pathogenic variant identified in episodic Ataxia type 2 and a potential link to sleep alleviated migraine.
Ahuja AS; Rozen TD; Atwal PS
BMC Neurol; 2019 Oct; 19(1):246. PubMed ID: 31640633
[TBL] [Abstract][Full Text] [Related]
7. Spinocerebellar ataxia type 6 with positional vertigo and acetazolamide responsive episodic ataxia.
Jen JC; Yue Q; Karrim J; Nelson SF; Baloh RW
J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):565-8. PubMed ID: 9771787
[TBL] [Abstract][Full Text] [Related]
8. Episodic ataxia associated with a de novo SCN2A mutation.
Leach EL; van Karnebeek CD; Townsend KN; Tarailo-Graovac M; Hukin J; Gibson WT
Eur J Paediatr Neurol; 2016 Sep; 20(5):772-6. PubMed ID: 27328862
[TBL] [Abstract][Full Text] [Related]
9. Functional implications of a novel EA2 mutation in the P/Q-type calcium channel.
Spacey SD; Hildebrand ME; Materek LA; Bird TD; Snutch TP
Ann Neurol; 2004 Aug; 56(2):213-20. PubMed ID: 15293273
[TBL] [Abstract][Full Text] [Related]
10. Missense CACNA1A mutation causing episodic ataxia type 2.
Denier C; Ducros A; Durr A; Eymard B; Chassande B; Tournier-Lasserve E
Arch Neurol; 2001 Feb; 58(2):292-5. PubMed ID: 11176968
[TBL] [Abstract][Full Text] [Related]
11. Early-onset progressive ataxia associated with the first CACNA1A mutation identified within the I-II loop.
Cricchi F; Di Lorenzo C; Grieco GS; Rengo C; Cardinale A; Racaniello M; Santorelli FM; Nappi G; Pierelli F; Casali C
J Neurol Sci; 2007 Mar; 254(1-2):69-71. PubMed ID: 17292920
[TBL] [Abstract][Full Text] [Related]
12. Congenital ataxia and hemiplegic migraine with cerebral edema associated with a novel gain of function mutation in the calcium channel CACNA1A.
García Segarra N; Gautschi I; Mittaz-Crettol L; Kallay Zetchi C; Al-Qusairi L; Van Bemmelen MX; Maeder P; Bonafé L; Schild L; Roulet-Perez E
J Neurol Sci; 2014 Jul; 342(1-2):69-78. PubMed ID: 24836863
[TBL] [Abstract][Full Text] [Related]
13. Detection of a novel missense mutation and second recurrent mutation in the CACNA1A gene in individuals with EA-2 and FHM.
Friend KL; Crimmins D; Phan TG; Sue CM; Colley A; Fung VS; Morris JG; Sutherland GR; Richards RI
Hum Genet; 1999 Sep; 105(3):261-5. PubMed ID: 10987655
[TBL] [Abstract][Full Text] [Related]
14. [Missense mutation R1345Q in CACNA1A gene causes a new type of ataxia with episodic tremor: clinical features, genetic analysis and treatment in a familial case].
Jiang HS; Wang DM; Wang Q; Yang M; Wang W; Pan SY; Hu YF
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jun; 36(7):883-6. PubMed ID: 27435762
[TBL] [Abstract][Full Text] [Related]
15. Familial migraine with vertigo: no mutations found in CACNA1A.
Kim JS; Yue Q; Jen JC; Nelson SF; Baloh RW
Am J Med Genet; 1998 Sep; 79(2):148-51. PubMed ID: 9741473
[TBL] [Abstract][Full Text] [Related]
16. Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine.
Strupp M; Kalla R; Dichgans M; Freilinger T; Glasauer S; Brandt T
Neurology; 2004 May; 62(9):1623-5. PubMed ID: 15136697
[TBL] [Abstract][Full Text] [Related]
17. Novel frameshift mutation in the CACNA1A gene causing a mixed phenotype of episodic ataxia and familiar hemiplegic migraine.
Kinder S; Ossig C; Wienecke M; Beyer A; von der Hagen M; Storch A; Smitka M
Eur J Paediatr Neurol; 2015 Jan; 19(1):72-4. PubMed ID: 25468264
[TBL] [Abstract][Full Text] [Related]
18. Clinical spectrum of episodic ataxia type 2.
Jen J; Kim GW; Baloh RW
Neurology; 2004 Jan; 62(1):17-22. PubMed ID: 14718690
[TBL] [Abstract][Full Text] [Related]
19. Late onset hereditary episodic ataxia.
Damak M; Riant F; Boukobza M; Tournier-Lasserve E; Bousser MG; Vahedi K
J Neurol Neurosurg Psychiatry; 2009 May; 80(5):566-8. PubMed ID: 19372292
[TBL] [Abstract][Full Text] [Related]
20. Acetazolamide improves neurotological abnormalities in a family with episodic ataxia type 2 (EA-2).
Harno H; Hirvonen T; Kaunisto MA; Aalto H; Levo H; Isotalo E; Somer H; Kallela M; Palotie A; Wessman M; Färkkilä M
J Neurol; 2004 Feb; 251(2):232-4. PubMed ID: 14991363
[No Abstract] [Full Text] [Related]
[Next] [New Search]
